Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 332 followers
Latest posts
Last updated 1 day ago
BioNTech advances DualityBio ADC into phase 3 with half the patients of Merck-Daiichi rival
1 day ago
BioNTech and partner DualityBio are accelerating the development of their B7-H3 ADC...
Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
1 day ago
On some level, Eli Lilly’s partnership with computing giant Nvidia feels inevitable...
How physiology powers biotech innovation
1 day ago
From AI to wearables, physiology turns data into discovery and drives smarter...
Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates
1 day ago
A new biotech has risen from the ashes of Novartis’ red-hot $12...
FDA slams ExThera with warning letter over controversial blood filter device
1 day ago
The FDA slammed ExThera with a warning letter for deviating from the...
Chutes & Ladders—Sarepta CEO to step down as DM1 hits close to home
1 day ago
A “fairly shocking and certainly ironic twist of fate” is ending Sarepta...
Earendil pens $885M pact to use WuXi XDC’s linker tech for next-gen ADCs
1 day ago
AI research biotech Earendil Labs has penned a $885 million deal to...
Thermo Fisher unveils test to aid in dosing of antirejection drug
1 day ago
Thermo Fisher Scientific is launching a new test it says can help...
Generate scores largest biotech IPO since 2024 with $400M Nasdaq listing
2 days ago
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from...
Spatial Biomarker Panels for Clinical Trials
2 days ago
This webinar covers how recent advances in multiplex immunofluorescence technology are enabling...
‘Like talking to a brick wall’: Senate hearing takes aim at FDA’s rare disease review process
2 days ago
A panel of physicians, biotech leaders and patient advocates took aim at...
As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress
2 days ago
A new highly sensitive cell therapy was able to wipe out three...